Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swiss Stem Cell Science (Swiss SDC) is a Swiss biotechnology company specializing in the collection, processing, and cryopreservation of stem cells for therapeutic and regenerative purposes. Based in the Ticino region, the company operates state-of-the-art laboratories dedicated to stem cell research and clinical applications in regenerative medicine. Swiss SDC provides services for the storage of stem cells from various sources, including umbilical cord blood and adipose tissue, ensuring high-quality standards for future medical use. The company also engages in research and development to advance stem cell-based therapies for a range of medical conditions and anti-aging treatments. By combining clinical expertise with advanced cryopreservation technology, Swiss SDC aims to provide patients with personalized regenerative medicine solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swiss SDC.